Runyu Dong

593 total citations
12 papers, 479 citations indexed

About

Runyu Dong is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Runyu Dong has authored 12 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Runyu Dong's work include Peptidase Inhibition and Analysis (4 papers), Signaling Pathways in Disease (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Runyu Dong is often cited by papers focused on Peptidase Inhibition and Analysis (4 papers), Signaling Pathways in Disease (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Runyu Dong collaborates with scholars based in United States, China and Belgium. Runyu Dong's co-authors include Martin Hegen, Chikao Morimoto, Junichi Kameoka, Stuart F. Schlossman, S F Schlossman, Toshiaki Tanaka, Yan Xu, Kouichi Tachibana, D. Cho and C Morimoto and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Runyu Dong

12 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Runyu Dong United States	10	296	196	126	112	90	12	479
Chikao Morimoto United States	13	156 0.5×	190 1.0×	59 0.5×	26 0.2×	363 4.0×	14	721
Anastasia Mpakali Greece	15	342 1.2×	319 1.6×	89 0.7×	11 0.1×	199 2.2×	25	610
Abhishek S. Kashyap Switzerland	9	225 0.8×	186 0.9×	6 0.0×	23 0.2×	123 1.4×	14	489
Srimathi Srinivasan United States	9	160 0.5×	208 1.1×	23 0.2×	22 0.2×	93 1.0×	15	408
Elena A Feshchenko United States	12	114 0.4×	379 1.9×	27 0.2×	5 0.0×	152 1.7×	13	558
Kenji Nakamaru Japan	10	217 0.7×	296 1.5×	8 0.1×	36 0.3×	18 0.2×	23	512
Gregory B. Carey United States	14	118 0.4×	303 1.5×	63 0.5×	4 0.0×	207 2.3×	27	573
Lennart Ivarsson Austria	11	108 0.4×	518 2.6×	11 0.1×	37 0.3×	187 2.1×	12	829
Cornelia Escher Germany	7	86 0.3×	336 1.7×	21 0.2×	9 0.1×	231 2.6×	7	542
Christie Fanton United States	11	288 1.0×	198 1.0×	10 0.1×	14 0.1×	267 3.0×	26	587

Countries citing papers authored by Runyu Dong

Since Specialization

Citations

This map shows the geographic impact of Runyu Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runyu Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runyu Dong more than expected).

Fields of papers citing papers by Runyu Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Runyu Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runyu Dong. The network helps show where Runyu Dong may publish in the future.

Co-authorship network of co-authors of Runyu Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Runyu Dong. A scholar is included among the top collaborators of Runyu Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Runyu Dong. Runyu Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Dong, Runyu, Yi‐Ren He, Peng Gao, et al.. (2025). Lactylation‐Driven HECTD2 Limits the Response of Hepatocellular Carcinoma to Lenvatinib. Advanced Science. 12(15). e2412559–e2412559. 11 indexed citations

2.

Dong, Runyu, Zhixiong Wang, Danping Cao, et al.. (2024). The ‘Other’ subfamily of HECT E3 ubiquitin ligases evaluate the tumour immune microenvironment and prognosis in patients with hepatocellular carcinoma. IET Systems Biology. 18(1). 23–39. 5 indexed citations

3.

Cao, Danping, Zhixiong Wang, Runyu Dong, et al.. (2024). Circ_0008315 promotes tumorigenesis and cisplatin resistance and acts as a nanotherapeutic target in gastric cancer. Journal of Nanobiotechnology. 22(1). 519–519. 12 indexed citations

4.

Li, Yanna, Zhixiong Wang, Danping Cao, et al.. (2024). CircRHBDD1 promotes immune escape via IGF2BP2/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer. Journal of Translational Medicine. 22(1). 704–704. 22 indexed citations

5.

Papadopoulos, K., Wael A. Harb, Xiao Ma, et al.. (2018). Phase I study of KN035, a novel fusion Anti-PD-L1 antibody administered subcutaneously in patients with advanced solid tumors in the USA. Annals of Oncology. 29. viii405–viii405. 13 indexed citations

6.

Heymach, John V., Runyu Dong, Isaiah W. Dimery, et al.. (2004). ZD6474, a novel antiangiogenic agent, in combination with docetaxel in patients with NSCLC: Results of the run-in phase of a two-part, randomized phase II study. Journal of Clinical Oncology. 22(14_suppl). 3051–3051. 17 indexed citations

7.

Heymach, John V., Runyu Dong, Isaiah W. Dimery, et al.. (2004). ZD6474, a novel antiangiogenic agent, in combination with docetaxel in patients with NSCLC: Results of the run-in phase of a two-part, randomized phase II study. Journal of Clinical Oncology. 22(14_suppl). 3051–3051. 5 indexed citations

8.

Dong, Runyu, Kouichi Tachibana, Martin Hegen, et al.. (1998). Correlation of the epitopes defined by anti-CD26 mAbs and CD26 function. Molecular Immunology. 35(1). 13–21. 23 indexed citations

9.

Hegen, Martin, Junichi Kameoka, Runyu Dong, Stuart F. Schlossman, & Chikao Morimoto. (1997). Cross‐linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen‐activated protein kinase. Immunology. 90(2). 257–264. 73 indexed citations

10.

Dong, Runyu, Kouichi Tachibana, Martin Hegen, et al.. (1997). Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation. The Journal of Immunology. 159(12). 6070–6076. 98 indexed citations

11.

Dong, Runyu, Junichi Kameoka, Martin Hegen, et al.. (1996). Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. The Journal of Immunology. 156(4). 1349–1355. 177 indexed citations

12.

Tamai, H., Akinori Kimura, Runyu Dong, et al.. (1994). Resistance to autoimmune thyroid disease is associated with HLA-DQ.. The Journal of Clinical Endocrinology & Metabolism. 78(1). 94–97. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact